Sandrivette Johnson
Nurse Practitioner · Raleigh, NCNPI 1740201458
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $369,415 of the $572,550 with a category attached, or 64.5%. 37 manufacturers reported payments, led by AbbVie at 25.5% of the total. Among nurse practitioner clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,896 payments — averaging $301.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$146K
- Johnson & Johnson$91K
- Sanofi$46K
- Lilly USA, LLC$40K
- Arcutis Biotherapeutics, Inc.$40K
- E.r. Squibb & Sons, L.L.C.$31K
- plus $179K from 31 others
What the payments were for
- Consulting fees$105,22118%
- Speaking & faculty fees$369,41565%
- Travel & lodging$62,51711%
- Food & beverage$34,9156%
- Education$3660%
- Gifts$1170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 425 | $146,202 |
| Johnson & Johnson | 221 | $91,424 |
| Sanofi | 130 | $45,755 |
| Lilly USA, LLC | 118 | $39,710 |
| Arcutis Biotherapeutics, Inc. | 64 | $39,639 |
| E.r. Squibb & Sons, L.L.C. | 98 | $30,624 |
| UCB, Inc. | 74 | $28,275 |
| LEO Pharma Inc. | 129 | $25,759 |
| Regeneron Healthcare Solutions, Inc. | 102 | $22,356 |
| Janssen Scientific Affairs, LLC | 33 | $20,180 |
| Amgen | 85 | $18,661 |
| Dermavant Sciences, Inc. | 54 | $18,023 |
| Galderma Laboratories, L.p. | 38 | $12,045 |
| Incyte Corporation | 79 | $8,454 |
| Eli Lilly | 8 | $7,705 |
| Novartis | 73 | $4,811 |
| LNHC, Inc | 12 | $4,644 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $1,936 |
| Sun Pharmaceutical Industries Inc. | 47 | $1,666 |
| Pfizer | 44 | $1,641 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $1,310 |
| Mayne Pharma Commercial LLC | 9 | $535 |
| Regeneron | 4 | $456 |
| Organon | 4 | $171 |
| Almirall LLC | 7 | $133 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Botanix SB Inc | 3 | $55 |
| Boehringer Ingelheim | 3 | $53 |
| Genentech USA, Inc. | 3 | $50 |
| VYNE Pharmaceuticals Inc. | 3 | $48 |
| EPI Health, LLC | 3 | $40 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Merz North America, Inc. | 1 | $22 |
| Journey Medical Corporation | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
| Dermira, Inc. | 1 | $20 |
| Strata Skin Sciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$572,550 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 28 | $190,939 |
| AdbryTralokinumab-Ldrm | 17 | $64,647 |
| Clobetasol Propionate | 111 | $4,379 |
| Doxycycline Hyclate | 90 | $2,710 |
| Betamethasone Dipropionate | 49 | $2,373 |
| Tacrolimus | 18 | $1,810 |
| Fluorouracil | 15 | $1,774 |
| Triamcinolone Acetonide | 104 | $1,517 |
| Dutasteride | 52 | $1,298 |
| Metronidazole | 21 | $1,224 |
| Ketoconazole | 78 | $1,109 |
| Tretinoin | 12 | $1,074 |
| Fluocinolone Acetonide | 20 | $1,006 |
| Spironolactone | 45 | $839 |
| ValacyclovirValacyclovir Hcl | 12 | $515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $146,202 | $190,93928 claims |
| LEO Pharma Inc.Adbry | $25,759 | $64,64717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Raleigh
- Stephanie PascaleRaleigh$54K
- Victoria PoillucciRaleigh$23K
- Ayeshia WrightMocksville$145K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
- Deborah MayerChapel Hill$55K
- Amber SeilerGreensboro$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.